The biologics formulation landscape is becoming increasingly complex as next-generation therapeutics push beyond conventional monoclonal antibodies into highly sophisticated modalities including antibody-drug conjugates (ADCs), bispecifics, multispecifics, personalised vaccines, and novel biologic combinations.

This eBook highlights leading solution providers helping biologics developers overcome formulation bottlenecks across:

• Stability optimisation
• Aggregation control
• High concentration formulation
• Excipient innovation
• Drug product development
• Fill-finish technologies
• Analytical characterisation
• Delivery systems
• Lyophilisation
• Cold-chain and stability management
• ADC conjugate stability
• Bispecific manufacturability
• Vaccine formulation scalability

This eBook is brought to you in conjunction with BioFormulate Live 2026, co-located with Biologics Manufacturing UK & BioOutsourcing UK. BioFormulate Live will continue bringing together formulation leaders, innovators, and solution providers to accelerate the next generation of biologics development.

It is is a dedicated industry platform focused on solving biologics formulation and drug product development challenges across next-generation modalities.

The event connects:

• Formulation scientists
• Drug product leaders
• Analytical development teams
• Process development experts
• CMC specialists
• Technology innovators
• CDMOs and solution providers

Through expert-led discussions, networking, and solution showcases, BioFormulate Live supports the advancement of innovative biologics from development through commercialisation.